反応式
[CH:1]([N:4]1[C:12]2[C:7](=[CH:8][CH:9]=[C:10]([N+:13]([O-])=O)[CH:11]=2)[C:6]([C:16]2[CH:23]=[CH:22][C:19]([C:20]#[N:21])=[CH:18][CH:17]=2)=[CH:5]1)([CH3:3])[CH3:2].[H][H]>O1CCCC1.[Pt]=O>[NH2:13][C:10]1[CH:11]=[C:12]2[C:7]([C:6]([C:16]3[CH:17]=[CH:18][C:19]([C:20]#[N:21])=[CH:22][CH:23]=3)=[CH:5][N:4]2[CH:1]([CH3:2])[CH3:3])=[CH:8][CH:9]=1参加物
5
実験手順
Method E Placc 4-(1-isopropyl-6-nitro-1H-indol-3-yl)-benzonitrile (4, R1=i-Pr, R3=4-benzonitrile) 250 mg, 0.82 mmol) in a 50 mL flask and add a suspension of platinum (II) oxide (16 mg) in tetrahydrofuran (9 mL). Place the reaction under 1 atmosphere of hydrogen and stir until the starting material is consumed. Filter through a celite pad and wash the pad with ethyl acetate (50 mL). Concentrate the combined filtrates to give 225.0 mg of the title compound (99%). LRMS (API ES+)=276.0 (M+H).
後処理
- customis consumed
- filtrationFilter through a celite pad
- washwash the pad with ethyl acetate (50 mL)
- concentrationConcentrate the combined filtrates
出典と根拠
- ORDレコード
- ord-91566e7c6935422598c04403973d2157
- 出典データセット
- uspto-grants-2011_04
- 特許番号
- US07932284B2
関連ノート
読み込み中…